MedTrace Logo

Effect Study of Clinical Outcomes of Traditional Chinese Medicine to Advanced Gastric Cancer by Propensity Score

NCT02781285 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2022-05-06

No results posted yet for this study

Summary

The researching subject is aimed to obtain the clinical evidences (including real benefits， risks ,etc. ) of traditional Chinese medicine in the treatment of advanced gastric cancer by compared with the outcomes that not accept the traditional Chinese medicine. the subject acquires these clinical practices by using the methods of multicenter、persisting registry (the real world researching technology ) and propensity score.

Conditions

  • Gastric Adenocarcinoma

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    collaborator OTHER

  • RenJi Hospital

    collaborator OTHER

  • Fudan University

    collaborator OTHER

  • ShuGuang Hospital

    collaborator OTHER

  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator OTHER

  • Ruijin Hospital

    collaborator OTHER

  • Yunnan Provinical Hospital of Traditional Chinese Medicine

    collaborator OTHER

  • Xiyuan Hospital of China Academy of Chinese Medical Sciences

    collaborator OTHER

  • Shaanxi Hospital of Traditional Chinese Medicine

    collaborator OTHER

  • Shanghai University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • zhao ai guang, Dr. · Shanghai Longhua Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2022-10-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02781285 on ClinicalTrials.gov